The present invention relates to targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor. In a preferred embodiment, the signal transduction pathway factor is an apoptosis-inducing factor, such as granzyme B, granzyme A, or Bax.

 
Web www.patentalert.com

< Drug delivery particle

> Boronic acid salts useful in parenteral formulations

~ 00432